Nzengue Jean-Christian, Zhan Wen-hua, Wang Jian-ping, Dong Wen-guang, Lan Ping, He Yu-long, Chen Zheng-xuan, Cai Shi-rong
Department of Gastroenteropancreatic Surgery, Gastric Cancer Research Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Nov;9(6):506-9.
To investigate the characteristics of lymph node metastases in advanced gastric cancer and its clinical significance.
From April 2002 to July 2003, we studied 91 patients with advanced gastric cancer who underwent radical gastrectomy and lymphadenectomy from which specimens were obtained during surgery. Then, collection of dissected lymph node, histopathological and immunohistological studies were performed to detect the lymph node metastasis rates and calculation. In addition, to analyze the relationship between lymph node metastasis rates and tumor diameters, TNM classification, Borrmann analysis, tumor localization and the extent of lymph node resection.
Among 91 patients with advanced gastric cancer, lymph node metastases were found in 63 patients (69.2%) with a total collection of 3149 lymph nodes and an average of 34.6 lymph nodes collected per patient. Lymph node metastasis rate was lower in tumor < 3 cm than that in tumor >3 cm. About TNM classification, lymph node metastases in advanced gastric cancer among patients in stage IIIa and stage IV was 100%, with the lymph node metastasis rates varying from 30.3% to 58.4%, which were significantly higher than that among patients in stage I and II (P<0.001). About Borrmann classification, lymph nodes metastasis in advanced gastric cancer among patients in Borrmann type III (79.6%) was higher than other Borrmann types, while in Borrmann type IV with the highest lymph node metastasis rate of 35.3% (P<0.05). Patients undergone lymph node dissection D(3) had higher lymph node metastases among patients and higher lymph node metastasis rate (88.2%, 38.0%) than patients in the D(1) and D(2) (P<0.05). Among 91 patients, 17 patients was found with micrometastasis (18.7%) from which 183 lymph nodes was collected, but no statistically significant difference between tumor location and micrometastasis was found (P>0.05). For tumor localization, lymph node metastases in proximal gastric cancer were more shown in station 1, 2, 3, 5, 7, 8, 9, 12, 13 and 16, with the highest metastasis rate in station 8 (68.1%). Lymph node metastases in middle gastric cancer were more shown in station 1, 3, 7, 12, 13 and 16, with the highest metastasis rate in station 3 (47.6%). Lymph node metastases in distal gastric cancer were more shown in station 1, 2, 3, 5, 6, 12, 13, and 16, with the highest metastasis rate in station 16 (83.3%).
Metastasis among patients and lymph node metastasis rates are significantly correlated with the severity of gastric malignancy and they may be valuable guideline to evaluate the extension of lymph nodes dissection in gastric cancer.
探讨进展期胃癌淋巴结转移的特点及其临床意义。
2002年4月至2003年7月,我们研究了91例行根治性胃切除术和淋巴结清扫术的进展期胃癌患者,术中获取标本。然后,进行解剖淋巴结的收集、组织病理学和免疫组织学研究,以检测淋巴结转移率并进行计算。此外,分析淋巴结转移率与肿瘤直径、TNM分期、Borrmann分型、肿瘤部位及淋巴结切除范围之间的关系。
91例进展期胃癌患者中,63例(69.2%)发现有淋巴结转移,共收集3149枚淋巴结,平均每位患者收集34.6枚淋巴结。肿瘤<3 cm的患者淋巴结转移率低于肿瘤>3 cm的患者。关于TNM分期,Ⅲa期和Ⅳ期进展期胃癌患者的淋巴结转移率为100%,转移率在30.3%至58.4%之间,显著高于Ⅰ期和Ⅱ期患者(P<0.001)。关于Borrmann分型,BorrmannⅢ型进展期胃癌患者的淋巴结转移率(79.6%)高于其他Borrmann型,而BorrmannⅣ型的淋巴结转移率最高,为35.3%(P<0.05)。行D(3)淋巴结清扫的患者淋巴结转移率高于D(1)和D(2)的患者,且淋巴结转移率更高(88.2%,38.0%)(P<0.05)。91例患者中,17例(18.7%)发现有微转移,共收集183枚淋巴结,但肿瘤部位与微转移之间未发现统计学差异(P>0.05)。对于肿瘤部位,近端胃癌的淋巴结转移多见于第1、2、3、5、7、8、9、12、13和16组,第8组转移率最高(68.1%)。胃中部癌的淋巴结转移多见于第1、3、7、12、13和16组,第3组转移率最高(47.6%)。远端胃癌的淋巴结转移多见于第1、2、3、5、6、12、13和16组,第16组转移率最高(83.3%)。
患者的转移情况及淋巴结转移率与胃癌恶性程度显著相关,可能是评估胃癌淋巴结清扫范围的有价值指标。